Rohto Cooling Eye Drops Recall
Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), Sterile 0.4 FL OZ (13 mL), Distributed by: The
Updated July 14, 2026
Rohto Cooling Eye Drops Max Strength (0.4 FL OZ / 13 mL bottles) has been recalled because the manufacturer cannot confirm the product is sterile. Using non-sterile eye drops can cause infection or irritation.
Is the Rohto-Mentholatum (Vietnam) Co., Ltd. recalled? Yes. This product was recalled by FDA on July 14, 2026. Details below.
What is recalled
Rohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90 0.2%), Sterile, 0.4 FL OZ (13 mL) bottles. UPC 310742011012, NDC 10742-8158-1. Distributed by The Mentholatum Company, Orchard Park, NY 14127. Made in Vietnam.
Am I affected
You're affected if you own a bottle of Rohto Cooling Eye Drops Max Strength (0.4 FL OZ / 13 mL) with UPC 310742011012 or NDC 10742-8158-1.
What to do right now
Stop using this eye drops product immediately. Do not put the drops in your eyes. Dispose of the bottle or return it to the retailer where you bought it. If you have used this product and experience eye redness, pain, discharge, or vision changes, contact your eye doctor.
The hazard
Lack of Assurance of Sterility
Brands affected
- Source
- FDA
- Category
- Drugs & Medications
- Recall ID
- fda-D-0716-2026
- Classification
- Class II
- Recalled
- July 14, 2026
Get free recall alerts
New Drugs & Medications recalls, the moment they post.
Free forever. Unsubscribe anytime. We never sell your data.
More Drugs & Medications recalls
Naropin Ropivacaine 0.5% Recall
Fresenius Kabi is recalling Naropin (ropivacaine hydrochloride injection) 0.5%, 20 mL single-dose vials because hair was found in some products. Use of …
Fresenius Kabi USA, LLC
Rohto Cooling Eye Drops Recall
Rohto Cooling Eye Drops Cool Relief has been recalled because the manufacturer cannot guarantee the product is sterile. Use of non-sterile eye drops can lead to …
Rohto-Mentholatum (Vietnam) Co., Ltd.
Major Pharmaceuticals Levothyroxine Recall
Major Pharmaceuticals is recalling Levothyroxine Sodium 88 mcg tablets because they are subpotent, meaning they contain less active ingredient than labeled. …
Major Pharmaceuticals